Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advancing clinical precision medicine via peripheral blood immune single-cell omics.

Clinical and translational medicine·2026

Same author

Regulation of transcription by R loop-nucleated transcription condensate assembly.

Cell & bioscience·2026

Same author

Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics.

Cancer cell international·2025

Same author

Chromosome X Open Reading Frame 38 (CXorf38) Is a Tumor Suppressor and Potential Prognostic Biomarker in Lung Adenocarcinoma: The First Characterization.

Proteomes·2025

Same author

Immobilized metal ion affinity chromatography: waltz of metal ions and biomacromolecules.

Expert review of proteomics·2025

Same author

The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update.

Epigenomics·2024

Search research articles

Related Experiment Video

Updated: Dec 7, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies.

Qi-Yao Wei¹, Yan-Ming Xu¹, Andy T Y Lau¹

¹Laboratory of Cancer Biology and Epigenetics, Department of Cell Biology and Genetics, Shantou University Medical College, Shantou 515041, Guangdong, China.

|October 1, 2020

Summary

This summary is machine-generated.

Nanoparticles enhance chemotherapy by improving drug delivery and reducing side effects for solid tumors. This review explores advanced nanocarrier designs for more effective and lasting cancer treatment.

Keywords:

drug delivery drug resistance nanotechnology solid tumor therapy

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Dec 7, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Area of Science:

Oncology
Nanotechnology
Pharmaceutical Sciences

Background:

Conventional chemotherapy faces challenges like poor selectivity, severe side effects, and drug resistance.
Nanoparticles (NPs) offer a promising approach to overcome these limitations in cancer therapy.
Nanotechnology has revolutionized oncology by enabling targeted drug delivery and improved drug efficacy.

Purpose of the Study:

To review recent advancements in nanocarrier design for chemotherapy.
To provide an overview of nanoparticle applications in treating various solid tumors.
To serve as a reference for future development of nano-pharmaceuticals.

Main Methods:

Review of current literature on nanocarriers in cancer treatment.
Analysis of different types of nano-pharmaceutical designs (liposomes, polymer NPs, etc.).
Examination of studies involving nanocarriers for solid tumor treatment.

Main Results:

Nanoparticles improve drug loading capacity, reduce toxicity, and enhance targeted delivery.
Optimized pharmacokinetic profiles and increased uptake at target sites are achieved with NPs.
Various nanocarriers have shown potential in treating lung, breast, pancreas, brain, and liver tumors.

Conclusions:

Nanotechnology significantly enhances the effectiveness of chemotherapy for solid tumors.
Novel nano-pharmaceutical designs are crucial for developing long-lasting and potent cancer treatments.
Further research into nanocarrier applications holds great promise for improving patient outcomes in oncology.